NextCell Pharma AB's total assets for Q1 2026 were kr63.92M, a decrease of -16.70% from the previous quarter. DE:65G total liabilities were kr13.32M for the fiscal quarter, a 28.76% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.